VP, RA
Graybug Vision, Inc
Fang has 30 years of drug development and more than 20 years of regulatory affairs experience. She worked across small molecules, biologics, gene therapy, over-the-counter products, in-vitro diagnostic products, and medical devices, with a focus on ophthalmology. Fang has a proven track record in negotiating and gaining regulatory approvals in the US and other regions. She is recognized for her thought leadership in product development ranging from pre-clinical, clinical, CMC, launch preparation to compliance, which originates from a deep understanding of patient needs and regulatory requirements.Fang started her career as a research scientist in breast cancer at Strang Cancer Prevention Center, Cornell University Weill Medical School. She holds a doctoral degree in medicinal chemistry from China Pharmaceutical University, Nanjing, a master’s degree in organic chemistry from Wuhan University, and a bachelor’s degree in organic chemistry from Xiamen University, P. R. China. Fang was a Carl Monder Fellow at The Population Council. She has held her US Regulatory Affairs Certification (RAC) since 2005, and co-chaired the NY/NJ Chapter of the Regulatory Affairs Professional Society (RAPS) in 2014 and 2015.
Disclosure information not submitted.
Monday, September 12, 2022
12:45 PM – 1:15 PM MST